Lei Dou

550 total citations
19 papers, 407 citations indexed

About

Lei Dou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lei Dou has authored 19 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Lei Dou's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lei Dou is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lei Dou collaborates with scholars based in China, Japan and Iran. Lei Dou's co-authors include Xinxin Zhang, Mohammad Mahdi Zangeneh, Kejun Guo, Xinxin Zhang, Yi Guo, Meng Yu, Yahong Zheng, Yajuan Chen, Yi Guo and Lu Li and has published in prestigious journals such as Cell Death and Disease, Frontiers in Oncology and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Lei Dou

18 papers receiving 401 citations

Peers

Lei Dou

ONCOL

Nooshin Shabab Iran

Yuxue Zhang China

Bryan Ngo United States

Binyuan Yan China

Serpil Oğuztüzün Türkiye

Dawei Sun China

Thumuluru Kavitha Madhuri United Kingdom

Zhilan Chen China

Caixia Lin China

Marina González Argentina

Nooshin Shabab Iran

Lei Dou

222 ×1.0

173 ×1.6

78 ×1.2

57 ×1.2

ONCOL

34 ×0.7

Citations per year, relative to Lei Dou Lei Dou (= 1×) peers Nooshin Shabab

Countries citing papers authored by Lei Dou

Since Specialization

Citations

This map shows the geographic impact of Lei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Dou more than expected).

Fields of papers citing papers by Lei Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Dou. The network helps show where Lei Dou may publish in the future.

Co-authorship network of co-authors of Lei Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Dou. A scholar is included among the top collaborators of Lei Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Dou. Lei Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dou, Lei, Dongli Tian, Lei Deng, et al.. (2024). Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer. Translational Oncology. 52. 102244–102244. 1 indexed citations

Liu, Shuangjie, Lei Dou, Miao Miao, et al.. (2023). HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 72–72. 8 indexed citations

Han, Tao, Tingsong Chen, Lüjun Chen, et al.. (2023). HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. Cell Death and Disease. 14(9). 606–606. 12 indexed citations

Dou, Lei, et al.. (2023). Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism. Journal of Translational Internal Medicine. 11(2). 169–177. 41 indexed citations

Dou, Lei, et al.. (2022). Perceived social support and depressive symptoms in Chinese patients with ovarian cancer and the mediating role of resilience:a cross-sectional study. Current Psychology. 42(24). 20485–20491. 4 indexed citations

Dou, Lei, et al.. (2022). Tips and Details for Successful Robotic Myomectomy: Single-Center Experience with the First 125 Cases. Journal of Clinical Medicine. 11(11). 3221–3221. 3 indexed citations

Zhang, Xinxin, Yi Zhang, & Lei Dou. (2021). miR-552 promotes the proliferation and metastasis of cervical cancer cells through targeting MUC15 pathway. Journal of Cancer. 12(20). 6094–6104. 4 indexed citations

Dou, Lei & Yi Zhang. (2021). miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance. Frontiers in Oncology. 11. 614035–614035. 16 indexed citations

Dou, Lei, et al.. (2021). Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway. Chinese Medical Journal. 135(4). 456–461. 15 indexed citations

10.

Dou, Lei & Xinxin Zhang. (2021). Upregulation of CCT3 promotes cervical cancer progression through FN1. Molecular Medicine Reports. 24(6). 18 indexed citations

11.

Dou, Lei, et al.. (2020). Efficient biogenesis of Cu2O nanoparticles using extract of Camellia sinensis leaf: Evaluation of catalytic, cytotoxicity, antioxidant, and anti-human ovarian cancer properties. Bioorganic Chemistry. 106. 104468–104468. 61 indexed citations

12.

Liu, Ning, Lei Dou, & Xinxin Zhang. (2020). <p>LncRNA PTTG3P Sponge Absorbs microRNA-155-5P to Promote Metastasis of Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 5283–5291. 12 indexed citations

13.

Dong, Haiyan, et al.. (2018). Role of tumor-derived exosomes in tumor metastasis. 45(7). 427–431. 15 indexed citations

14.

Dou, Lei, Yahong Zheng, Lu Li, et al.. (2018). The effect of cinnamon on polycystic ovary syndrome in a mouse model. Reproductive Biology and Endocrinology. 16(1). 99–99. 80 indexed citations

15.

Dou, Lei, et al.. (2018). [An in vitro study of the angiogenic effects of concentrate growth factor on human umbilical vein endothelial cells].. PubMed. 36(3). 247–251.

16.

Dou, Lei, et al.. (2015). miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncology Reports. 35(3). 1645–1651. 36 indexed citations

17.

Li, Tian‐Ren, et al.. (2015). Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. Oncology Reports. 33(5). 2337–2344. 51 indexed citations

18.

Zheng, Gaofeng, et al.. (2015). Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.. PubMed. 8(6). 6505–11. 18 indexed citations

19.

Cai, Xue, Ying Qiao, Yongsheng Chen, et al.. (2014). Downregulation of TIM-3 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Brazilian Journal of Medical and Biological Research. 48(1). 77–82. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact